⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OPTH News
Optimi Health Corp. Common Shares
Optimi Health to Present at the ThinkEquity Conference
globenewswire.com
OPTH
Optimi Health Appoints Melanie Pump to Board of Directors
globenewswire.com
OPTH
Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply
globenewswire.com
OPTH
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
globenewswire.com
OPTH
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
globenewswire.com
OPTH
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
globenewswire.com
OPTH
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
OPTH
Optimi Health Establishes Discretionary Equity Facility
globenewswire.com
OPTH
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
prnewswire.com
OPTH
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
globenewswire.com
OPTH